Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Pharmaceuticals

    Pharmaceuticals - Page 332

    FDC Ban: Drugs Technical Advisory Board to review efficacy, safety, justification of drugs

    FDC Ban: Drugs Technical Advisory Board to review efficacy, safety, justification of drugs

    Ruby Khatun Khatun16 Jan 2018 5:13 PM IST
    New Delhi: The Drugs Technical Advisory Board (DTAB) is expected to set up expert committees to review the safety, efficacy and therapeutic...
    Lupin forays into OTC segment, eyes Rs 300 crore turnover in 5 years

    Lupin forays into OTC segment, eyes Rs 300 crore turnover in 5 years

    Ruby Khatun Khatun16 Jan 2018 11:30 AM IST
    New Delhi: Drug major Lupin said it has forayed into over-the-counter (OTC) segment in the country with plans to touch Rs 300 crore turnover in the...
    Glenmark gets nod for phase II study of novel molecule

    Glenmark gets nod for phase II study of novel molecule

    Ruby Khatun Khatun16 Jan 2018 11:00 AM IST
    New Delhi: Glenmark Pharmaceuticals said it has received nod from Directorate General of Health Services, Central Drugs Standard Control Organisation,...
    Over 92 percent people do not trust healthcare system in India: Study

    Over 92 percent people do not trust healthcare system in India: Study

    Ruby Khatun Khatun16 Jan 2018 10:48 AM IST
    New Delhi: Over 92 percent people do not trust healthcare system in India, with the hospital being the most distrusted organization followed by Pharma...
    LIC sells over 2 percent stake in Merck

    LIC sells over 2 percent stake in Merck

    Ruby Khatun Khatun16 Jan 2018 10:00 AM IST
    New Delhi: Life Insurance Corporation has sold a little over 2 percent stake in drug and chemical firm Merck Ltd through an open market...
    German watchdog calls for direct comparison of cancer immunotherapies

    German watchdog calls for direct comparison of cancer immunotherapies

    Ruby Khatun Khatun16 Jan 2018 9:30 AM IST
    FRANKFURT: Germany’s drug assessment body has criticized a lack of data directly comparing drugs in a promising new class of cancer immunotherapy,...
    NITI Aayog asked to revamp process of drug selection for price control

    NITI Aayog asked to revamp process of drug selection for price control

    Ruby Khatun Khatun15 Jan 2018 4:19 PM IST
    New Delhi: The system of selections of drugs for Price Control may now undergo a sea change as the government has asked the NITI Aayog to revamp the...
    ED arrests former Andhra Bank director in Sterling Biotech loan fraud case

    ED arrests former Andhra Bank director in Sterling Biotech loan fraud case

    Ruby Khatun Khatun15 Jan 2018 10:30 AM IST
    New Delhi: A former Director of Andhra Bank has been arrested by the Enforcement Directorate (ED) in connection with its money laundering probe in the...
    State, Johnson and Johnson partner for rural health training

    State, Johnson and Johnson partner for rural health training

    Ruby Khatun Khatun15 Jan 2018 10:00 AM IST
    Mumbai: The Maharashtra Health department and private firm Johnson and Johnson entered into an agreement to train rural midwives and accredited social...
    Sparks price for Luxturna blindness gene therapy too high: ICER

    Spark's price for Luxturna blindness gene therapy too high: ICER

    Ruby Khatun Khatun15 Jan 2018 9:45 AM IST
    The proposed price for Spark Therapeutics Inc’s groundbreaking one-time gene therapy for a rare form of blindness is far too high, an independent U.S....
    Google venture arm backs UK universal flu vaccine company

    Google venture arm backs UK universal flu vaccine company

    Ruby Khatun Khatun15 Jan 2018 9:30 AM IST
    LONDON: A private British company developing a vaccine that would be the first in the world to fight all types of flu has raised 20 million pounds...
    Aurobindo, Zydus Cadila, Torrent Pharma show interest to buy Sanofi 2 billion dollar European generics business

    Aurobindo, Zydus Cadila, Torrent Pharma show interest to buy Sanofi 2 billion dollar European generics business

    Ruby Khatun Khatun14 Jan 2018 11:51 AM IST
    MUMBAI: Aurobindo, Zydus Cadila, Torrent Pharma and Intas have shown their interest to buy the European generics business of pharma giant...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    FDC Ban: Avoid These Combinations of Paracetamol

    FDC Ban: Avoid These Combinations of Paracetamol

    Delhi High Court directs RSSB chief Dhillon, family to undertake Singh brothers dues to Daiichi

    Delhi High Court directs RSSB chief Dhillon, family to undertake Singh brothers dues to Daiichi

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok